KPT-330-mediated XPO1 inhibition impairs homologous recombination and enhances radiosensitivity in extranodal NK/T-cell lymphoma

Huijie Zhou, Qiuluo Liu, Kexing Ren, Qian Luo, Chunli Yang, Tian Fang, Xi Chen, Liqun Zou · 2026

Read KPT-330-mediated XPO1 inhibition impairs homologous recombination and enhances radiosensitivity in extranodal NK/T-cell lymphoma by Huijie Zhou, Qiuluo Liu, Kexing Ren, Qian Luo, Chunli Yang, Tian Fang, Xi Chen, Liqun Zou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13534731.txt.

Description

Huijie Zhou and colleagues report in 2026 that blocking XPO1, a cell export protein, weakens DNA repair and boosts radiation effect in extranodal NK/T-cell lymphoma. The rare, aggressive lymphoma often resists radiation when disease returns. Tumour samples showed high XPO1 levels tied to worse survival.

Removing one copy of the gene impaired faithful repair, and the drug KPT-330 copied that defect and paired well with radiation. The drug traps a growth factor inside the nucleus, lowering repair genes. Two heavily treated patients responded to combined care with manageable side effects.

Catalog record

CREATORHuijie Zhou, Qiuluo Liu, Kexing Ren, Qian Luo, Chunli Yang, Tian Fang, Xi Chen, Liqun Zou
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44940
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13534731

Browse the full library · About the Tower of Babel